Skip to main content
Faes Farma S.A. logo

Faes Farma S.A. — Investor Relations & Filings

Ticker · FAE ISIN · ES0134950F36 LEI · 959800FXZQY7U3P1G969 MC Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2023-06-27 Regulatory Filings
Country ES Spain
Listing MC FAE

About Faes Farma S.A.

https://faesfarma.com/en/

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Recent filings

Filing Released Lang Actions
Noticias sobre bilastina
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). It announces two key business updates: the approval of the drug Bilastine in China and the termination of the licensing agreement for Bilastine in the USA. This type of material, disclosing significant, non-public, market-moving information to the regulator, is typically classified as a general regulatory filing or announcement that doesn't fit the specific financial report categories (like 10-K, ER, or IR). Given the nature of the announcement (business development/legal/commercial update) and the lack of a specific category for 'Other Relevant Information' outside of general regulatory filings, the most appropriate classification is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory disclosures.
2023-06-27 Spanish
La Sociedad informa de las operaciones sobre acciones propias realizadas del 19 al 23 de junio al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication addressed to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator). The content explicitly details the execution of a share repurchase program ('programa de recompra de acciones propias') over a specific period (June 19 to June 23, 2023), providing detailed transaction tables (date, quantity, price). This activity falls directly under the definition of a company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2023-06-26 Spanish
La Sociedad informa de las operaciones sobre acciones propias realizadas del 12 al 16 de junio al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication addressed to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details transactions carried out by the company ('Faes Farma, S.A.') involving the purchase of its own shares ('compra de acciones propias') as part of a previously approved share repurchase program ('programa de recompra de acciones propias'). This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The filing date is June 19, 2023, reporting transactions from June 12 to June 16, 2023. This fits the definition for Code: POS.
2023-06-19 Spanish
Cambios Comisiones
AGM Information Classification · 99% confidence The document is addressed to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV), indicating a regulatory filing in Spain. The content explicitly details agreements adopted by the Board of Directors following the Ordinary General Meeting (Junta General Ordinaria), specifically concerning the composition and appointments within the Board Committees (Nombramientos y Retribuciones, Auditoría y Cumplimiento) and the designation of the Coordinating Director (Consejero coordinador). This information directly relates to changes in the composition of the board of directors and senior management structure, which aligns perfectly with the definition for Board/Management Information (MANG). It is not an AGM presentation (AGM-R), a general earnings release (ER), or a formal annual report (10-K). Given the short length and specific content about board appointments, MANG is the most appropriate classification.
2023-06-15 Spanish
La Sociedad informa de las operaciones sobre acciones propias realizadas del 5 al 9 de junio al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details transactions carried out by Faes Farma, S.A. regarding the 'programa de recompra de acciones propias' (own share repurchase program) over a specific period (June 5 to June 9, 2023). This involves the company buying back its own shares. According to the definitions, the category 'Transaction in Own Shares' (Code: POS) covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document is a detailed report of these transactions, not just an announcement of a future report.
2023-06-12 Spanish
La Sociedad informa de las operaciones sobre acciones propias realizadas del 29 de mayo al 2 de junio al amparo de su Programa de Recompra.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details the execution of a share repurchase program ('programa de recompra de acciones propias') over a specific period (May 29, 2023, to June 2, 2023), including transaction dates, quantities, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2023-06-05 Spanish

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.